RxDoctor Payments Data

Glen Patton, DO

Family Medicine · Derby, KSNPI 1922073337

Payments from drug & device makers

$10,797in general payments, 2019–2025

Across 670 payments — averaging $16.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$992
  • Amgen$724
  • Abbott$450
  • plus $4K from 43 others

What the payments were for

  • Food & beverage$10,72299%
  • Education$751%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,797 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$124,445
Medicare patients
304
Services billed
16,244

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide46$50,210
JanuviaSitagliptin Phosphate35$34,059
EliquisApixaban22$25,097
Repatha SureclickEvolocumab22$11,877
XareltoRivaroxaban14$10,187
Breo ElliptaFluticasone/Vilanterol21$10,029
JardianceEmpagliflozin12$8,613
ShingrixVaricella-Zoster Ge/As01b/Pf28$6,147
LinzessLinaclotide13$6,001
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen207$5,866
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen228$5,620
Lantus SolostarInsulin Glargine,hum.Rec.Anlog37$4,629
Fluticasone-SalmeterolFluticasone Propion/Salmeterol43$3,898
Levothyroxine Sodium303$3,508
Butalb-Acetaminoph-Caff-CodeinButalbit/Acetamin/Caff/Codeine34$3,290

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,523$50,21046 claims
MerckJanuvia$247$34,05935 claims
PfizerEliquis$174$25,09722 claims
GSKBreo Ellipta, Shingrix$440$16,17649 claims
Johnson & JohnsonXarelto$381$10,18714 claims
AbbVieLinzess, Synthroid$1,437$9,09645 claims
Boehringer IngelheimJardiance$95$8,61312 claims
Lilly USA, LLCHumalog$992$84513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Derby

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →